Research Study

Pycnogenol® Reduces Risk of Post-Thrombotic Syndrome and Recurrent Thrombosis

Published

Format: PDF file | Document type: Research Study

Pycnogenol® Reduces Risk of Post-Thrombotic Syndrome and Recurrent Thrombosis

Related categories: Gut/digestive health, Immune support

New research shows daily supplementation with Pycnogenol® may reduce the incidence of post-thrombotic syndrome (PTS) and recurrent thrombosis, a potentially life-threatening condition that may occur as a long-term complication of deep vein thrombosis (DVT). Pycnogenol® was shown to perform better than aspirin, ticlopidine and sulodexide in the treatment of DVT and PTS symptoms during the six year study.

Related resources from Horphag Research

Show more

Supplier info centre